Andrew Mamalis1, Manveer Garcha, Jared Jagdeo. 1. Department of Dermatology, University of California Davis, Sacramento, California; Dermatology Service, Sacramento VA Medical Center, Mather, California.
Abstract
BACKGROUND AND OBJECTIVE: Blue light is part of the visible light spectrum that does not generate harmful DNA adducts associated with skin cancer and photoaging, and may represent a safer therapeutic modality for treatment of keloid scars and other fibrotic skin diseases. Our laboratory previously demonstrated that light-emitting diode (LED) red and infrared light inhibits proliferation of skin fibroblasts. Moreover, different wavelengths of light can produce different biological effects. Furthermore, the effects of LED blue light (LED-BL) on human skin fibroblasts are not well characterized. This study investigated the effects of LED-BL on human skin fibroblast proliferation, viability, migration speed, and reactive oxygen-species (ROS) generation. METHODS AND MATERIALS: Irradiation of adult human skin fibroblasts using commercially-available LED-BL panels was performed in vitro, and modulation of proliferation and viability was quantified using the trypan blue dye exclusion assay, migratory speed was assessed using time-lapse video microscopy, and intracellular ROS generation was measured using the dihydrorhodamine flow cytometry assay. Statistical differences between groups were determined by ANOVA and Student's t-test. RESULTS: Human skin fibroblasts treated with LED-BL fluences of 5, 10, 15, 30, and 80 J/cm(2) demonstrated statistically significant dose-dependent decreases in relative proliferation of 8.4%, 29.1%, 33.8%, 51.7%, and 55.1%, respectively, compared to temperature and environment matched bench control plates, respectively. LED-BL fluences of 5, 30, 45, and 80 J/cm(2) decreased fibroblast migration speed to 95 ± 7.0% (P = 0.64), 81.3 ± 5.5% (P = 0.021), 48.5 ± 2.7% (P < 0.0001), and 32.3 ± 1.9% (P < 0.0001), respectively, relative to matched controls. LED fluences of 5, 10, 30, and 80 J/cm(2) resulted in statistically significant increases in reactive oxygen species of 110.4%, 116.6%, 127.5%, and 130%, respectively, relative to bench controls. CONCLUSION: At the fluences studied, LED-BL can inhibit adult human skin dermal fibroblast proliferation and migration speed, and is associated with increased reactive oxygen species generation in a dose-dependent manner without altering viability. LED-BL has the potential to contribute to the treatment of keloids and other fibrotic skin diseases and is worthy of further translational and clinical investigation.
BACKGROUND AND OBJECTIVE: Blue light is part of the visible light spectrum that does not generate harmful DNA adducts associated with skin cancer and photoaging, and may represent a safer therapeutic modality for treatment of keloid scars and other fibrotic skin diseases. Our laboratory previously demonstrated that light-emitting diode (LED) red and infrared light inhibits proliferation of skin fibroblasts. Moreover, different wavelengths of light can produce different biological effects. Furthermore, the effects of LED blue light (LED-BL) on human skin fibroblasts are not well characterized. This study investigated the effects of LED-BL on human skin fibroblast proliferation, viability, migration speed, and reactive oxygen-species (ROS) generation. METHODS AND MATERIALS: Irradiation of adult human skin fibroblasts using commercially-available LED-BL panels was performed in vitro, and modulation of proliferation and viability was quantified using the trypan blue dye exclusion assay, migratory speed was assessed using time-lapse video microscopy, and intracellular ROS generation was measured using the dihydrorhodamine flow cytometry assay. Statistical differences between groups were determined by ANOVA and Student's t-test. RESULTS:Human skin fibroblasts treated with LED-BL fluences of 5, 10, 15, 30, and 80 J/cm(2) demonstrated statistically significant dose-dependent decreases in relative proliferation of 8.4%, 29.1%, 33.8%, 51.7%, and 55.1%, respectively, compared to temperature and environment matched bench control plates, respectively. LED-BL fluences of 5, 30, 45, and 80 J/cm(2) decreased fibroblast migration speed to 95 ± 7.0% (P = 0.64), 81.3 ± 5.5% (P = 0.021), 48.5 ± 2.7% (P < 0.0001), and 32.3 ± 1.9% (P < 0.0001), respectively, relative to matched controls. LED fluences of 5, 10, 30, and 80 J/cm(2) resulted in statistically significant increases in reactive oxygen species of 110.4%, 116.6%, 127.5%, and 130%, respectively, relative to bench controls. CONCLUSION: At the fluences studied, LED-BL can inhibit adult human skin dermal fibroblast proliferation and migration speed, and is associated with increased reactive oxygen species generation in a dose-dependent manner without altering viability. LED-BL has the potential to contribute to the treatment of keloids and other fibrotic skin diseases and is worthy of further translational and clinical investigation.
Authors: James A Fauerbach; Leslie J Heinberg; John W Lawrence; Amy G Bryant; Linda Richter; Robert J Spence Journal: Health Psychol Date: 2002-03 Impact factor: 4.267
Authors: S B Brych; L H Engrav; F P Rivara; J T Ptacek; D C Lezotte; P C Esselman; K J Kowalske; N S Gibran Journal: J Burn Care Rehabil Date: 2001 Nov-Dec
Authors: J A Fauerbach; L J Heinberg; J W Lawrence; A M Munster; D A Palombo; D Richter; R J Spence; S S Stevens; L Ware; T Muehlberger Journal: Psychosom Med Date: 2000 Jul-Aug Impact factor: 4.312
Authors: Sneha S Kelkar; Eleanor McCabe-Lankford; Richard Albright; Phil Harrington; Nicole H Levi-Polyachenko Journal: Lasers Surg Med Date: 2016-09-16 Impact factor: 4.025
Authors: Cláudio Daniel Cerdeira; Maísa Ribeiro Pereira Lima Brigagão; Marina Lara Carli; Cláudia de Souza Ferreira; Gabriel de Oliveira Isac Moraes; Henrique Hadad; João Adolfo Costa Hanemann; Michael R Hamblin; Felipe Fornias Sperandio Journal: J Biophotonics Date: 2016-05-31 Impact factor: 3.207
Authors: Yan Wu; Tingting Zhu; Yaoyao Yang; Hong Gao; Chunxia Shu; Qiang Chen; Juan Yang; Xiang Luo; Yao Wang Journal: Lasers Med Sci Date: 2021-03-15 Impact factor: 3.161
Authors: Yucheng Wang; Ying Wang; Yuguang Wang; Clinton K Murray; Michael R Hamblin; David C Hooper; Tianhong Dai Journal: Drug Resist Updat Date: 2017-10-13 Impact factor: 18.500
Authors: Hyun Soo Lee; Soo-Eun Jung; Sue Kyung Kim; You-Sun Kim; Seonghyang Sohn; You Chan Kim Journal: Ann Dermatol Date: 2017-03-24 Impact factor: 1.444